Perioperative Outcomes and 5-year Survival After Open versus Thoracoscopic Sleeve Resection for Lung Cancer. Seminars in thoracic and cardiovascular surgery Mayne, N. R., Darling, A. J., Raman, V. n., Balderson, S. n., Berry, M. F., Harpole, D. H., D'Amico, T. A., Yang, C. J. 2020


The objective of this study was to evaluate the impact of a video-assisted thoracoscopic (VATS) approach on outcomes in patients who underwent sleeve lobectomy for non-small-cell lung cancer (NSCLC). Outcomes of patients with cT1-T3, N0-N2, M0 NSCLC who underwent sleeve lobectomy in the National Cancer Data Base (NCDB) from 2010-2015 were assessed using Kaplan-Meier, propensity score-matching, and Cox proportional hazards analyses. An "intent-to-treat" analysis was performed. In the NCDB, 210 sleeve lobectomy patients met inclusion criteria (VATS 44 [21%], thoracotomy 166 [79%]). Nine (20%) of the VATS cases were converted to open. Compared to an open approach, VATS was associated with no significant differences in lymph nodes examined (median 9.5 vs 9.0, p?=?0.72), length of stay (median 6 days vs 6 days, p?=?0.36), 30-day mortality (4.5% vs 1.8%; p?=?0.28), and 90-day mortality (6.8% vs 4.8%; p?=?0.70). There were no significant differences in 5-year survival between the VATS and open groups in both the entire cohort (VATS [85%] vs open [79%]; log-rank p?=?0.91) and in a propensity score-matched analysis of 86 patients (log-rank p?=?0.75). Furthermore, a VATS approach was also not associated with worse survival in multivariable analysis (HR?=?0.64; 95% CI [0.23-1.78]; p?=?0.39). In this national analysis, a VATS approach for sleeve lobectomy for NSCLC was not associated with worse short-term or long-term outcomes when compared to an open approach.

View details for DOI 10.1053/j.semtcvs.2020.08.013

View details for PubMedID 32858216